Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000528459) titled 'Optimised Transcranial Magnetic Stimulation for the Treatment of Depression (OptiTMS)' on May 26.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: The University of Melbourne
Condition:
Treatment-resistant depression
Treatment-resistant depression
Mental Health - Depression
Intervention:
Transcranial Magnetic Stimulation (TMS) is a promising non-invasive therapy (ie. it does not involve surgery or the introduction of instruments into the body) for treatment o...